Copy to clipboard 
Royal DSM announced Eric Teutsch’s appointment as President of DSM Biomedical. He succeeds Gerard de Reuver, who had served as the company’s interim president since November 2015.
As president, Teutsch will oversee the strategic development and execution of DSM Biomedical’s global activities. Under his leadership, DSM Biomedical will continue to strengthen existing technology platforms and will explore opportunities to form strategic partnerships that complement its activities in the medical device market.
Teutsch joins DSM from Stryker, where he was Vice President and General Manager of the Orthobiologics Division. In his nearly 30 years at Stryker, Teutsch led the acquisition, integration and operation of ten new product lines and businesses and led four new stand-alone business divisions.
Source: DSM Biomedical
In December 2015, FDA cleared DSM’s Dyneema Purity® Radiopaque Cerclage Cable for use in orthopaedic trauma treatments, such as bone and spine fractures. That decision marked the first clearance for a device fully designed and developed by DSM’s Biomedical Polyethylenes Team.
